Skip to main content
Log in

Minimally invasive surgical approach for the treatment of gastroparesis

Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Gastroparesis is a chronic disorder resulting in decreased quality of life. The gastric electrical stimulator (GES) is an alternative to gastrectomy in patients with medically refractory gastroparesis. The aim of this study was to analyze the outcomes of patients treated with the gastric stimulator versus patients treated with laparoscopic subtotal or total gastrectomy.

Methods

A retrospective chart review was performed of all patients who had surgical treatment of gastroparesis from January 2003 to January 2012. Postoperative outcomes were analyzed and symptoms were assessed with the Gastroparesis Cardinal Symptom Index (GCSI).

Results

There were 103 patients: 72 patients (26 male/46 female) with a GES, implanted either with laparoscopy (n = 20) or mini-incision (n = 52), and 31 patients (9 male/22 female) who underwent laparoscopic subtotal (n = 27), total (n = 1), or completion gastrectomy (n = 3). Thirty-day morbidity rate (8.3 % vs. 23 %, p = 0.06) and in-hospital mortality rate (2.7 % vs. 3 %, p = 1.00) were similar for GES and gastrectomy. There were 19 failures (26 %) in the group of GES patients; of these, 13 patients were switched to a subtotal gastrectomy for persistent symptoms (morbidity rate 7.7 %, mortality 0). In total, 57 % of patients were treated with GES while only 43 % had final treatment with gastrectomy. Of the GES group, 63 % rated their symptoms as improved versus 87 % in the primary gastrectomy group (p = 0.02). The patients who were switched from GES to secondary laparoscopic gastrectomy had 100 % symptom improvement. The median total GCSI score did not show a difference between the procedures (p = 0.12).

Conclusion

The gastric electrical stimulator is an effective treatment for medically refractory gastroparesis. Laparoscopic subtotal gastrectomy should also be considered as one of the primary surgical treatments for gastroparesis given the significantly higher rate of symptomatic improvement with acceptable morbidity and comparable mortality. Furthermore, the gastric stimulator patients who have no improvement of symptoms can be successfully treated by laparoscopic subtotal gastrectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Monnikes H, van der Voort IR (2006) Gastric electrical stimulation in gastroparesis: where do we stand? Dig Dis 24(3–4):260–266

    PubMed  Google Scholar 

  2. Yin J et al (2012) Gastric neuromodulation with Enterra System for nausea and vomiting in patients with gastroparesis. Neuromodulation 15(3):224–231

    Article  PubMed  Google Scholar 

  3. Chu H et al (2012) Treatment of high-frequency gastric electrical stimulation for gastroparesis. J Gastroenterol Hepatol 27(6):1017–1026

    Article  PubMed  Google Scholar 

  4. Soykan I et al (1998) Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 43(11):2398–2404

    Article  PubMed  CAS  Google Scholar 

  5. Reardon TM et al (1989) Surgical therapy of diabetic gastroparesis. J Clin Gastroenterol 11(2):204–207

    Article  PubMed  CAS  Google Scholar 

  6. Arts J et al (2007) Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 26(9):1251–1258

    Article  PubMed  CAS  Google Scholar 

  7. Bromer MQ et al (2005) Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 61(7):833–839

    Article  PubMed  Google Scholar 

  8. Friedenberg FK et al (2008) Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 103(2):416–423

    Article  PubMed  CAS  Google Scholar 

  9. Houston H et al (2003) First year experience of patients undergoing the Stretta procedure. Surg Endosc 17(3):401–404

    Article  PubMed  CAS  Google Scholar 

  10. Lacy BE et al (2004) The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care 27(10):2341–2347

    Article  PubMed  CAS  Google Scholar 

  11. Noar MD, Noar E (2008) Gastroparesis associated with gastroesophageal reflux disease and corresponding reflux symptoms may be corrected by radiofrequency ablation of the cardia and esophagogastric junction. Surg Endosc 22(11):2440–2444

    Article  PubMed  Google Scholar 

  12. Hibbard ML, Dunst CM, Swanstrom LL (2011) Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement. J Gastrointest Surg 15(9):1513–1519

    Article  PubMed  Google Scholar 

  13. Zarate N et al (2003) Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management. Gut 52(7):966–970

    Article  PubMed  CAS  Google Scholar 

  14. Brody F et al (2008) Gastric electrical stimulation for gastroparesis. J Am Coll Surg 207(4):533–538

    Article  PubMed  Google Scholar 

  15. Mason RJ et al (2005) Gastric electrical stimulation: an alternative surgical therapy for patients with gastroparesis. Arch Surg 140(9):841–846 discussion 847–848

    Article  PubMed  Google Scholar 

  16. McCallum RW et al (2011) Gastric electrical stimulation improves outcomes of patients with gastroparesis for up to 10 years. Clin Gastroenterol Hepatol 9(4):314–319

    Article  PubMed  Google Scholar 

  17. Forster J et al (2003) Further experience with gastric stimulation to treat drug refractory gastroparesis. Am J Surg 186(6):690–695

    Article  PubMed  Google Scholar 

  18. Lin Z et al (2004) Effect of high-frequency gastric electrical stimulation on gastric myoelectric activity in gastroparetic patients. Neurogastroenterol Motil 16(2):205–212

    Article  PubMed  CAS  Google Scholar 

  19. Watkins PJ, Buxton-Thomas MS, Howard ER (2003) Long-term outcome after gastrectomy for intractable diabetic gastroparesis. Diabet Med 20(1):58–63

    Article  PubMed  CAS  Google Scholar 

  20. Revicki DA et al (2003) Development and validation of a patient-assessed gastroparesis symptom severity measure: the gastroparesis cardinal symptom index. Aliment Pharmacol Ther 18(1):141–150

    Article  PubMed  CAS  Google Scholar 

  21. Revicki DA et al (2004) Gastroparesis cardinal symptom index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res 13(4):833–844

    Article  PubMed  Google Scholar 

  22. Parkman HP, Hasler WL, Fisher RS (2004) American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology 127(5):1589–1591

    Article  PubMed  Google Scholar 

  23. Cassilly DW et al (2008) Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy. Digestion 78(2–3):144–151

    Article  PubMed  Google Scholar 

  24. Lin Z et al (2004) Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation. Diabetes Care 27(5):1071–1076

    Article  PubMed  Google Scholar 

  25. Velanovich V (2008) Quality of life and symptomatic response to gastric neurostimulation for gastroparesis. J Gastrointest Surg 12(10):1656–1662 discussion 1662–1663

    Article  PubMed  Google Scholar 

Download references

Disclosure

Dr. John Lipham is a consultant for Medtronic. Dr. Zehetner, Dr. Ravari, Dr. Ayazi, Dr. Skibba, Dr. Darehzereshki, Dr. Pelipad, Dr. Mason, and Dr. Katkhouda have no conflicts of interest or financial ties to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John C. Lipham.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zehetner, J., Ravari, F., Ayazi, S. et al. Minimally invasive surgical approach for the treatment of gastroparesis. Surg Endosc 27, 61–66 (2013). https://doi.org/10.1007/s00464-012-2407-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-012-2407-0

Keywords

Navigation